Cassava Sciences | PTIE - Capitalisation Boursière





Capitalisation Boursière Changement Date
Abbott USD 178.41B 39.46B 2026-03
Amgen USD 189.89B 13.64B 2026-03
Biogen USD 26.9B 1.09B 2026-03
Cara Therapeutics USD 366M 338M 2025-09
Cassava Sciences USD 52M 30M 2026-07
Eisai JPY 1.42T 110.62B 2026-03
Eli Lilly USD 869.02B 146.97B 2026-03
Geron USD 955M 112M 2026-03
J&J USD 579.15B 78.91B 2026-03
Merck USD 297.1B 35.84B 2026-03
Novartis USD 307.76B 15.54B 2026-03
Novavax USD 1.09B 316M 2025-12
Pfizer USD 153.81B 12.24B 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12